Search

Search results

142 results found

Initiated Major Grants for siRNA-Based Prophylactics for RSV Infections (2006)

In 2006, Dr. Shyam Mohapatra initiated major research grants to develop siRNA-based prophylactics for respiratory syncytial virus (RSV). He secured a VA Merit Review award (April 2005–March 2009) to study RNA-interference strategies targeting the virus’s NS1 and NS2 genes, laying the groundwork for...

Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2.

Jana, Indrani Das, Prabuddha Bhattacharya, Karthick Mayilsamy, Saptarshi Banerjee, Gourab Bhattacharje, Sayan Das, Seemanti Aditya, et al. 2022. “Targeting an Evolutionarily Conserved ‘E-L-L’ Motif in the Spike Protein to Develop a Small Molecule Fusion Inhibitor Against SARS-CoV-2.”. BioRxiv : The Preprint Server for Biology.

Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury.

Mayilsamy, Karthick, Eleni Markoutsa, Mahasweta Das, Pratik Chopade, Durga Puro, Akanksha Kumar, Danielle Gulick, Alison E Willing, Shyam S Mohapatra, and Subhra Mohapatra. 2020. “Treatment With ShCCL20-CCR6 Nanodendriplexes and Human Mesenchymal Stem Cell Therapy Improves Pathology in Mice With Repeated Traumatic Brain Injury.”. Nanomedicine : Nanotechnology, Biology, and Medicine 29: 102247.